Healthcare Business Trends

Susan Dentzer: Is consolidation in healthcare the work of modern-day robber barons — or the result of overdue reengineering?

The most successful industrialists of America’s Gilded Age were often skewered by contemporary critics as being robber barons. A new generation of naysayers wants to recycle the old rhetoric, this time targeting organizations focused on healthcare: The critics’ clear message: Big money is helping healthcare get bigger, and it’s a bad deal all around. Many…

Susan Dentzer, MS October 2, 2023

News Briefs: Reports quantify how cost increases will affect the healthcare industry in 2024 

The cost to treat patients will accelerate in the upcoming year, according to newly published projections.  PwC’s Health Research Institute reported that the cost of providing care will increase by 7%, up from a 6% increase this year and 5.5% in 2022. A 7% increase would tie 2021 for the highest annual change in the…

Nick Hut September 30, 2023

Risky business: What every CFO should know before taking on risk

As a health system leader, how can you ensure your organization is making the right moves to take on risk in an evolving landscape for payment? Check out a handful of key capabilities to focus on in this article.

HFMA September 29, 2023

New approaches to nonclinical workforce management

Five healthcare leaders in revenue cycle management and patient access share their approach to workforce management in a remote and/or hybrid model and lessons learned along the way.

HFMA September 29, 2023

Summary: 10 vital responses to healthcare disruption

Note: This article is a summary of a report on HFMA’s Spring Thought Leadership Retreat. The full report is available to download. Disruption is reverberating throughout the healthcare industry, and it’s incumbent on legacy organizations to develop strategic responses for the benefit of their consumers, their communities and themselves. With that overarching challenge becoming ever…

Nick Hut August 30, 2023

Key questions for providers after more than 2 years of the price transparency rule

Evidence amassed from over two years of experience with compliance reinforces why providers need to focus on chargemaster prices and self-pay discount policies — and how they can benefit from analyzing trends in consumers’ price searches.

Fred Stodolak August 25, 2023

HFMA, Selat/Nawa and KSA Ministry of Health collaborate on one-day educational event in Riyadh

The Healthcare Financial Management Association (HFMA) is offering a new international educational opportunity with a one-day healthcare finance event, at the Global Health Exhibition in Riyadh on Oct. 31. Selat, a Riyadh-based revenue cycle management consulting firm and its training arm Nawa, is the exclusive sponsor of the event and will also provide instruction during…

Betty Hintch, CHFP August 18, 2023

The latest on hospital finances: Signs of improvement, but margins remain tight

Industry-level hospital financial insights reflect the mixed results of a recovery that’s in progress but is expected to be a long slog. In a 2023 midyear report (login required), Moody’s Investors Service noted that margins are below 3% for a third of the company’s rated hospitals. Before the pandemic, only about 6% had margins in…

Nick Hut July 27, 2023

10 Vital Responses to Healthcare Disruption

Disruption is reverberating throughout the healthcare industry, and it’s incumbent on legacy organizations to develop strategic responses for the benefit of their consumers, their communities and themselves. With that overarching challenge becoming ever more pressing, HFMA’s 2023 Spring Thought Leadership Retreat brought together leaders from across the industry May 4-5 in Atlanta to consider approaches…

Nick Hut July 11, 2023

Annual Conference: Healthcare entrepreneur Alex Oshmyansky describes his efforts to disrupt drug pricing

Arguably no segment of the healthcare industry is more susceptible to disruption than the market for prescription drugs, as Alex Oshmyansky, MD, PhD, made clear Wednesday morning during the closing session of HFMA’s Annual Conference. Oshmyansky spoke about his personal efforts to disrupt the pharmaceutical market in his role as co-founder and CEO of Mark…

Nick Hut June 28, 2023
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );